Group One Trading’s AbbVie ABBV Stock Holding History

Group One Trading’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$31.2M	Sell	143,400 -56,500	-28%	-$12.5M	0.06%	318
2025 Q4	$45.7M	Sell	199,900 -15,900	-7%	-$3.62M	0.08%	233
2025 Q3	$50M	Buy	215,800 +10,600	+5%	+$2.16M	0.09%	213
2025 Q2	$38.1M	Buy	205,200 +71,100	+53%	+$13.2M	0.08%	216
2025 Q1	$28.1M	Sell	134,100 -69,000	-34%	-$13.4M	0.08%	218
2024 Q4	$36.1M	Buy	203,100 +59,800	+42%	+$11M	0.08%	204
2024 Q3	$28.3M	Buy	143,300 +80,100	+127%	+$14.9M	0.08%	192
2024 Q2	$10.8M	Buy	63,200 +13,500	+27%	+$2.24M	0.04%	406
2024 Q1	$9.05M	Sell	49,700 -363,600	-88%	-$62.7M	0.03%	490
2023 Q4	$64M	Sell	413,300 -39,600	-9%	-$5.77M	0.17%	71
2023 Q3	$67.5M	Buy	452,900 +35,300	+8%	+$5.18M	0.23%	49
2023 Q2	$56.3M	Buy	417,600 +11,100	+3%	+$1.63M	0.18%	63
2023 Q1	$64.8M	Sell	406,500 -437,200	-52%	-$66.8M	0.23%	47
2022 Q4	$136M	Buy	843,700 +38,600	+5%	+$5.92M	0.32%	36
2022 Q3	$108M	Sell	805,100 -230,900	-22%	-$33.1M	0.21%	49
2022 Q2	$159M	Buy	1,036,000 +223,900	+28%	+$34.2M	0.25%	39
2022 Q1	$132M	Sell	812,100 -408,800	-33%	-$59.4M	0.13%	87
2021 Q4	$165M	Buy	1,220,900 +660,900	+118%	+$78.1M	0.13%	80
2021 Q3	$60.4M	Sell	560,000 -196,800	-26%	-$22.5M	0.07%	235
2021 Q2	$85.2M	Buy	756,800 +302,700	+67%	+$34.1M	0.1%	138
2021 Q1	$49.1M	Sell	454,100 -294,400	-39%	-$31.5M	0.07%	223
2020 Q4	$80.2M	Buy	748,500 +230,100	+44%	+$22.1M	0.14%	92
2020 Q3	$45.4M	Sell	518,400 -8,400	-2%	-$791K	0.14%	106
2020 Q2	$51.7M	Buy	526,800 +314,600	+148%	+$27.7M	0.24%	61
2020 Q1	$16.2M	Sell	212,200 -30,700	-13%	-$2.61M	0.13%	139
2019 Q4	$21.5M	Buy	242,900 +6,600	+3%	+$548K	0.15%	130
2019 Q3	$17.9M	Sell	236,300 -109,800	-32%	-$7.53M	0.14%	126
2019 Q2	$25.2M	Buy	346,100 +187,200	+118%	+$14.7M	0.23%	64
2019 Q1	$12.8M	Sell	158,900 -84,400	-35%	-$6.9M	0.14%	132
2018 Q4	$22.4M	Buy	243,300 +61,300	+34%	+$5.39M	0.19%	94
2018 Q3	$17.2M	Sell	182,000 -41,400	-19%	-$3.93M	0.14%	140
2018 Q2	$20.7M	Buy	223,400 +114,100	+104%	+$11.1M	0.18%	92
2018 Q1	$10.3M	Sell	109,300 -329,000	-75%	-$36.1M	0.1%	217
2017 Q4	$42.4M	Sell	438,300 -82,400	-16%	-$7.77M	0.3%	51
2017 Q3	$46.3M	Sell	520,700 -15,700	-3%	-$1.2M	0.42%	23
2017 Q2	$38.9M	Sell	536,400 -133,000	-20%	-$8.94M	0.4%	28
2017 Q1	$43.6M	Buy	669,400 +18,400	+3%	+$1.16M	0.51%	19
2016 Q4	$40.8M	Buy	651,000 +303,900	+88%	+$18.5M	0.4%	34
2016 Q3	$21.9M	Sell	347,100 -38,500	-10%	-$2.49M	0.24%	73
2016 Q2	$23.9M	Buy	385,600 +199,200	+107%	+$12.1M	0.28%	53
2016 Q1	$10.6M	Sell	186,400 -354,300	-66%	-$19.7M	0.15%	126
2015 Q4	$32M	Buy	540,700 +38,500	+8%	+$2.22M	0.38%	26
2015 Q3	$27.3M	Sell	502,200 -171,200	-25%	-$11.1M	0.38%	24
2015 Q2	$45.2M	Buy	673,400 +300,500	+81%	+$19.6M	0.63%	11
2015 Q1	$21.8M	Buy	372,900 +41,500	+13%	+$2.51M	0.34%	34
2014 Q4	$21.7M	Sell	331,400 -41,800	-11%	-$2.64M	0.33%	41
2014 Q3	$21.6M	Buy	373,200 +289,900	+348%	+$16.1M	0.33%	35
2014 Q2	$4.7M	Sell	83,300 -86,700	-51%	-$4.55M	0.07%	322
2014 Q1	$8.74M	Buy	170,000 +12,500	+8%	+$632K	0.15%	120
2013 Q4	$8.32M	Sell	157,500 -10,100	-6%	-$496K	0.13%	142
2013 Q3	$7.5M	Buy	167,600 +57,500	+52%	+$2.55M	0.14%	118
2013 Q2	$4.55M	Buy	+110,100	New	+$4.82M	0.11%	167

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Group One Trading's ABBV Position: Q3 2024 in Review

Group One Trading sold out of AbbVie (ABBV) in Q3 2024, closing a stake of 15,610 shares — an estimated $2.91M sold.

Group One Trading first reported a position in ABBV in Q2 2013 and held it in 23 quarters. The position peaked at $23M in Q1 2015. 3,498 funds tracked by Wall St. Rank hold ABBV as of Q3 2024.

Group One Trading reported no remaining AbbVie position as of Q3 2024 after selling out during the quarter.
Group One Trading sold 15,610 AbbVie shares in Q3 2024, an estimated $2.91M.
Group One Trading first reported a position in AbbVie in Q2 2013 and held it in 23 quarters.
Group One Trading's AbbVie position peaked at $23M in Q1 2015.
3,498 funds tracked by Wall St. Rank held AbbVie as of Q3 2024.

Based on Group One Trading's 13F filing for Q3 2024, filed 14 Nov 2024.